| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/07/2006 | EP1663146A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 06/07/2006 | EP1663111A2 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/07/2006 | EP1663109A2 Ultrasonic concentration of drug delivery capsules |
| 06/07/2006 | EP1663106A2 Pharmaceutical composition, method of manufacturing and therapeutic use thereof |
| 06/07/2006 | EP1663061A2 Use of melatonin-containing oral supplement with animals |
| 06/07/2006 | EP1662874A2 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 06/07/2006 | EP1542730B1 Modified therapeutic agents |
| 06/07/2006 | EP1476467B1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 06/07/2006 | EP1453447A4 Composition and transdermal drug delivery device |
| 06/07/2006 | EP1446106A4 Optimal polymer mixtures for gastric retentive tablets |
| 06/07/2006 | EP1411899A4 Taste masking composition |
| 06/07/2006 | EP1383537B1 Novel chocolate composition as delivery system for nutrients and medications |
| 06/07/2006 | EP1305009B1 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 06/07/2006 | EP1296673A4 Antimicrobial coatings |
| 06/07/2006 | EP1265630B1 Use of insulin for the treatment of cartilagenous disorders |
| 06/07/2006 | EP1222931B1 Percutaneous absorption promoters for electroporation |
| 06/07/2006 | EP1200039B1 Emulsifier-free finely dispersed water-in-oil-type systems |
| 06/07/2006 | EP1174126B1 Antibody and polyalkylene glycol-bonded liposome |
| 06/07/2006 | EP1140965B1 Antibacterial protonated oligonucleotides |
| 06/07/2006 | EP1124592B1 Textured and porous silicone rubber |
| 06/07/2006 | EP1121941B1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 06/07/2006 | EP1107794B1 Therapeutic compositions for the treatment of mucus hypersecretion |
| 06/07/2006 | EP0969873B1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 06/07/2006 | CN1784436A Polymer products |
| 06/07/2006 | CN1784244A Prodrugs cleavable by CD26 |
| 06/07/2006 | CN1784237A Freeze-dried preparation containing methylcobalamin and process for producing the same |
| 06/07/2006 | CN1784228A Novel compositions |
| 06/07/2006 | CN1784227A Dosage form containing pantoprazole as active ingredient |
| 06/07/2006 | CN1784219A Ultraviolet-shielding type patch |
| 06/07/2006 | CN1784216A Nutritional supplement composition and method |
| 06/07/2006 | CN1781854A Biofilm carrier with improved specific surfacial area,bio-affinity and flowability |
| 06/07/2006 | CN1781555A High viscosity liquid controlled delivery system |
| 06/07/2006 | CN1781545A Method for extracting herbal medicine |
| 06/07/2006 | CN1781499A Dampproof Chinese medicine sranular agent and its preparing method |
| 06/07/2006 | CN1781487A OCT preparations |
| 06/07/2006 | CN1258551C Preparing method of degradable polymer |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/07/2006 | CN1258361C Breath freshening film |
| 06/07/2006 | CN1258360C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/07/2006 | CN1258358C Polymeric micelle composition |
| 06/06/2006 | US7057165 Probe for mass spectrometry |
| 06/06/2006 | US7057019 Crosslinked albumin hydrogels |
| 06/06/2006 | US7056951 Stabilizers to inhibit the formation of a lactam, comprising a composition that is known to reduce ionic activity (such as an alcohol, ketone, stearate or cellulose derivative); and at least 20 ppm of an anion. |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056886 GLP-2 formulations |
| 06/06/2006 | US7056729 Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056539 Synergistic herbal combination |
| 06/06/2006 | US7056533 Medicament incorporation matrix |
| 06/06/2006 | US7056532 supramolecular complex of an uncrosslinked block polymer having a nonionic, water soluble segment and a polyanionic segment, and a hydrophobic surfactant having a charge opposite to the charge of the polymer; increased bioavailability; decreased side effects; site-specific drug delivery |
| 06/06/2006 | US7056530 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 06/06/2006 | US7056529 Vesicle comprises ATP and phospholipid; fusion proteins |
| 06/06/2006 | US7056528 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 06/06/2006 | US7056527 Patches containing buprenorphine hydrochloride |
| 06/06/2006 | US7056526 Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption |
| 06/06/2006 | US7056525 Use thereof in human and animal foods, cosmetics and pharmaceuticals; soft gelatin capsules |
| 06/06/2006 | US7056524 Methods of hydrating mucosal surfaces |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | US7056500 Polymer conjugates of opioid antagonists |
| 06/06/2006 | US7056493 Radio-opaque polymer biomaterials |
| 06/06/2006 | US7056377 For the production of capsules and coatings for solid formulations in drug, cosmetic, food and dietetic fields, and for coating seeds. |
| 06/06/2006 | US7056332 making a suture by modifying an aqueous suspension of a nucleic acid, e.g., by capping, crosslinking, methylation, ethylation, or attachment of a protein, to form a viscous gel, which is extruded to form a filament; optionally adding a biodegradable polymer |
| 06/06/2006 | CA2457852C Multivesicular emulsion topical delivery systems |
| 06/06/2006 | CA2417686C Manufacture of oral dosage forms delivering both immediate release and sustained release drugs |
| 06/06/2006 | CA2376706C Antifungal oral composition containing itraconazole and process for preparing same |
| 06/06/2006 | CA2171303C Active principles and gas containing microparticles |
| 06/06/2006 | CA2169791C Process for the extraction of antioxidants from vegetable matter |
| 06/06/2006 | CA2160775C Transdermal therapeutic system containing estradiol |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/06/2006 | CA2071214C Method of delivering molecules into eukaryotic cells |
| 06/01/2006 | WO2006058109A1 Triple natural polymer viscoelastic composition |
| 06/01/2006 | WO2006058022A1 Compositions comprising azelastine and methods of use thereof |
| 06/01/2006 | WO2006057507A1 An oral preparation having improved bioavailability |
| 06/01/2006 | WO2006057429A1 Method of changing morphology of block copolymer |
| 06/01/2006 | WO2006057375A1 Medicinal preparation for external use |
| 06/01/2006 | WO2006057194A1 Solid agent and process for producing the same |
| 06/01/2006 | WO2006056713A1 Solid, oral, microparticulate dosage form which has been designed to prevent misuse |
| 06/01/2006 | WO2006056712A1 Solid, oral drug form which has been designed to prevent misuse |
| 06/01/2006 | WO2006056463A2 Method for the production of albumen conjugates with non-steroidal antirheumatic drugs (nsar) |
| 06/01/2006 | WO2006056312A1 Stable crystalline modifications of dotap chloride |
| 06/01/2006 | WO2006056227A1 Conjugates comprising the active agent and flanking or branched-chain peptides |
| 06/01/2006 | WO2006056204A1 Method of cross-linking hyaluronic acid with divinylsulfone |
| 06/01/2006 | WO2006056079A1 Formulations of pyridoxal -5'-phosphate and methods of preparation |
| 06/01/2006 | WO2006056078A1 Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 06/01/2006 | WO2006056064A1 Solid formulations of liquid biologically active agents |
| 06/01/2006 | WO2006041878A3 Primary examiner |
| 06/01/2006 | WO2006037116A3 Semi-solid delivery vehicle and pharmaceutical compositions |
| 06/01/2006 | WO2006032762A3 Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose |
| 06/01/2006 | WO2006031848A3 Corticosteroid topical dispersion with low content of surfactant |
| 06/01/2006 | WO2006020720A3 Stable pegylated interferon formulation |
| 06/01/2006 | WO2006020403A3 3-halo-2-oxopropionate salts and esters as novel anticancer agents |
| 06/01/2006 | WO2006020208A3 Therapeutic composition whit a botulinum neurotoxin |
| 06/01/2006 | WO2005117905A3 Systems and methods for treating panic attacks |
| 06/01/2006 | WO2005101993A9 Metal-containing nanolayered composites, and applications thereof |
| 06/01/2006 | WO2005099667A3 Drug delivery compositions |
| 06/01/2006 | WO2005097196A3 Pharmaceutical preparation containing drospirenone for application to the skin |
| 06/01/2006 | WO2005077422A3 Antibody linked cationic emulsions as drug delivery system |
| 06/01/2006 | WO2005063299A3 Compositions and methods for the treatment of tumor of hematopoietic origin |